Lidocaine Hydrochloride

Product NDC: 17856-0775
11-digit product format: 178560775
Labeler code: 17856
Product ID: 17856-0775_46636c35-5f80-4198-b20d-c891165938ee
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Lidocaine Hydrochloride
Dosage form: SOLUTION
Route: ORAL; TOPICAL
Labeler: ATLANTIC BIOLOGICALS CORP.
Application: ANDA040014
Marketing category: ANDA
Marketing start: 1995-07-10
Marketing end: 0000-00-00
Substance: LIDOCAINE HYDROCHLORIDE ANHYDROUS
Active strength: 20 mg/mL
Pharmacologic classes: Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 6 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	17856-0775		I	Inactivated by FDA	2026-08-10
excluded package	package	17856-0775	17856-0775-1	D	Discontinued by firm	2026-08-10
excluded package	package	17856-0775	17856-0775-2	D	Discontinued by firm	2026-08-10
excluded package	package	17856-0775	17856-0775-3	D	Discontinued by firm	2026-08-10
excluded package	package	17856-0775	17856-0775-4	D	Discontinued by firm	2026-08-10
excluded package	package	17856-0775	17856-0775-5	D	Discontinued by firm	2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 55 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17856-0775-3	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17856-0775-1	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17856-0775-2	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17856-0775-4	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17856-0775-5	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17856-0775-3	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17856-0775-1	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17856-0775-2	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17856-0775-4	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17856-0775-5	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	17856-0775-3	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	17856-0775-1	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	17856-0775-2	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	17856-0775-4	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	17856-0775-5	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	17856-0775-3	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	17856-0775-1	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	17856-0775-2	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	17856-0775-4	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	17856-0775-5	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	17856-0775-3	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	17856-0775-1	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	17856-0775-2	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	17856-0775-4	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	17856-0775-5	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	17856-0775-3	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	17856-0775-1	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	17856-0775-2	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	17856-0775-4	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	17856-0775-5	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	17856-0775-3	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	17856-0775-1	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	17856-0775-2	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	17856-0775-4	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	17856-0775-5	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	17856-0775-3	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	17856-0775-1	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	17856-0775-2	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	17856-0775-4	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	17856-0775-5	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	17856-0775-3	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	17856-0775-1	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	17856-0775-2	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	17856-0775-4	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	17856-0775-5	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17856-0775-1	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17856-0775-4	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17856-0775-2	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17856-0775-5	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17856-0775-1	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17856-0775-4	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17856-0775-2	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17856-0775-5	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A040014-001	LIDOCAINE HYDROCHLORIDE	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT		1995-07-10	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT		1995-07-10	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT		1995-07-10	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT		1995-07-10	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL			1995-07-10	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A040014-001	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT	RS	1995-07-10	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040014-001	AT	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040014-001	AT	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A040014-001	AT	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A040014-001	AT	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A040014-001	AT	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A040014-001	AT	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A040014-001	AT	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A040014-001	AT	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A040014-001	AT	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A040014-001	AT	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A040014-001	AT	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A040014-001	AT	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A040014-001	AT	1	`ea99ee380514…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A040014-001	AT	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A040014-001	AT	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A040014-001	AT	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A040014-001	AT	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A040014-001	AT	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A040014-001	AT	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A040014-001	AT	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A040014-001	AT	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A040014-001	AT	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A040014-001	AT	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
070fbed5-7088-434a-a7ce-f2a64d8d40ac	Product name	2	20260107
bee66ce1-adb7-9d3b-67d9-582e4c54e80f	Product name	5	20250819
860a93dc-4863-49cc-b284-6bbe8191bc48	Product name	4	20250214
eaba870a-6a9d-442e-8643-87b3f558a451	Product name	1	20250117
9b4cf230-fd05-41d5-98c6-5db9ecb27b86	Product name	1	20230117
7d755fa1-1087-4dcd-98f0-6d4bba479a57	Product name	3	20210602
aed701d5-9c75-dfaf-7154-cde46179faea	Product name	9	20200313
fa8b5901-e681-426f-82fe-54f6d81ec698	Product name	4	20180619
332d03e4-aa24-4b11-841a-02bf41081920	Product name	1	20171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070	Product name	1	20171221
68ed98f8-24c2-44a0-944a-6d36e82ce25a	Product name	1	20141222
1cd42bc2-a430-c72b-636d-991b235fbf80	Product name	1	20140508
49fa150c-f0de-cce7-3d9c-993ed81c5698	Product name	1	20140508
4d7ae718-ed00-bae8-2abe-9eaec1eef7ff	Product name	1	20140508
9137811f-f279-8640-5aeb-99fa2145d64d	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
17856-0775-1	2024-05-16	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%
17856-0775-2	2024-05-16	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%
17856-0775-3	2024-05-16	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%
17856-0775-4	2024-05-16	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%
17856-0775-5	2024-05-16	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%
17856-0775-1	2023-01-30	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%
17856-0775-2	2023-01-30	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%
17856-0775-3	2023-01-30	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%
17856-0775-4	2023-01-30	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%
17856-0775-5	2023-01-30	LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
17856-0775-1	Lidocaine Hydrochloride	10 mL in 1 CUP	SOLUTION	10	7
17856-0775-2	Lidocaine Hydrochloride	20 mL in 1 CUP	SOLUTION	20	7
17856-0775-3	Lidocaine Hydrochloride	20 mL in 1 SYRINGE	SOLUTION	20	7
17856-0775-4	Lidocaine Hydrochloride	15 mL in 1 CUP, UNIT-DOSE	SOLUTION	15	7
17856-0775-4	Lidocaine Hydrochloride	50 in 1 BOX	SOLUTION	50	7
17856-0775-5	Lidocaine Hydrochloride	5 mL in 1 CUP	SOLUTION	5	7

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
17856-0775-1	ML - Milliliter	17856-0775	50ec14ed-ee5c-469c-aa68-c691d6209f1b	1	2015-10-02
17856-0775-2	ML - Milliliter	17856-0775	dd0deb34-7258-4535-a118-ca4e09b0d9d3	1	2013-06-04
17856-0775-4	ML - Milliliter	17856-0775	bc9a07d5-9337-4d45-b2f1-87786effec97	1	2022-11-07

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LIDOCAINE HYDROCHLORIDE	ACTIVE INGREDIENT	V13007Z41A	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
LIDOCAINE	ACTIVE MOIETY	98PI200987	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
CARBOXYMETHYLCELLULOSE SODIUM	INACTIVE INGREDIENT	K679OBS311	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
ORANGE	INACTIVE INGREDIENT	5EVU04N5QU	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
SACCHARIN SODIUM DIHYDRATE	INACTIVE INGREDIENT	SB8ZUX40TY	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORPS]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17856-0775	LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORP.]	7	Legacy NDC, 6 package rows	20240517_2de0a467-1338-4515-8a94-0d6d85e204ca.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lidocaine Hydrochloride	LIDOCAINE HYDROCHLORIDE	NuCare Pharmaceuticals,Inc.	5a41d694-4628-4911-e053-2991aa0a91e5	2024-08-14	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040014 application number: ANDA040014

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
EC2CNF7XFP	LIDOCAINE HYDROCHLORIDE ANHYDROUS	73-78-9	LIDOCAINE HYDROCHLORIDE ANHYDROUS
V13007Z41A	LIDOCAINE HYDROCHLORIDE	6108-05-0	Lidocaine Hydrochloride

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1010739	lidocaine HCl 2 % Mucous Membrane Topical Solution	PSN	2de0a467-1338-4515-8a94-0d6d85e204ca	7
1010739	lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution	SCD	2de0a467-1338-4515-8a94-0d6d85e204ca	7
1010739	lidocaine HCl 2 % Oral Topical Solution	SY	2de0a467-1338-4515-8a94-0d6d85e204ca	7
1010739	lidocaine HCl 2 % Oromucosal Solution	SY	2de0a467-1338-4515-8a94-0d6d85e204ca	7

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
17856-0775-1	17856077501	10 mL in 1 CUP (17856-0775-1)	10 ml	2021-01-28	0000-00-00	No	No	Current
17856-0775-2	17856077502	20 mL in 1 CUP (17856-0775-2)	20 ml	2021-01-28	0000-00-00	No	No	Current
17856-0775-3	17856077503	20 mL in 1 SYRINGE	20 ml					Historical
17856-0775-4	17856077504	50 CUP, UNIT-DOSE in 1 BOX (17856-0775-4) > 15 mL in 1 CUP, UNIT-DOSE		2021-01-28	0000-00-00	No	No	Current
17856-0775-5	17856077505	5 mL in 1 CUP (17856-0775-5)	5 ml	2021-01-28	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOLUTION, USP (VISCOUS) 2%	ATLANTIC BIOLOGICALS CORP.	2024-05-16	HUMAN PRESCRIPTION DRUG LABEL	7